FMP
UBS Reiterates Neutral Rating on Exponent, Sees Potential for Growth in 2025
Jun 26, 2024 3:22 PM - Davit Kirakosyan
Image credit: FMP
UBS analysts reiterated their Neutral rating and maintained a price target of $88 on Exponent (NASDAQ:EXPO), following investor meetings with Exponent's CEO Catherine Corrigan and CFO Rich Schlenker.
The discussions revealed a stable demand environment, particularly in Consumer Electronics, which has shown modest sequential gains. The Reactive segment remains healthy, although slightly below the Q1 surge. Management indicated that sequential headcount growth might resume in the second half of the year, with year-over-year headcount growth anticipated in 2025. This could help Exponent return to its historical revenue growth algorithm in the high single-digit to low double-digit percentage range.
If achieved, this growth could surpass UBS's current estimate of a 5% increase. Despite being surprised by the stock's performance during Q1 earnings and its subsequent resilience, the analysts noted that management's optimistic outlook and the potential for stronger growth in 2025 could present a positive narrative for Exponent.
Other Blogs
Nov 22, 2024 5:08 AM - Parth Sanghvi
Fundamental Analysis: Principles, Types, and How to Use It
Fundamental analysis is one of the most essential tools for investors and analysts alike, helping them assess the intrinsic value of a stock, company, or even an entire market. It focuses on the financial health and economic position of a company, often using key data such as earnings, expenses, ass...
Dec 17, 2024 8:58 AM - Sanzhi Kobzhan
Examining Tesla’s Financial Health Using FinancialModelingPrep’s Ratios API
Tesla, one of the world’s most talked-about electric vehicle manufacturers, attracts a lot of attention from investors and market watchers. By examining a snapshot of Tesla’s financial ratios—such as those provided by FinancialModelingPrep’s Ratios API—we can get a clearer picture of the company’s f...
Dec 22, 2024 7:59 AM - Sanzhi Kobzhan
Two great Software Platform Stocks Similar to Palantir (PLTR)
When it comes to cutting-edge software and data analytics, Palantir Technologies (NYSE: PLTR) is often front and center. But for many investors, it’s important to consider alternative or complementary stocks in the same sector that may offer robust growth potential. As PLTR looks expensive (overvalu...
